Harrow (HROW) Change in Receivables (2014 - 2026)
Harrow (HROW) posted quarterly Change in Receivables of -$9.8 million for Q1 2026, up 74.92% year-over-year from -$5.6 million in Q1 2025, and down 129.6% quarter-over-quarter from $33.2 million in Q4 2025.
Harrow (HROW) Change in Receivables (2014 - 2026) Analysis & Trends
Harrow's Change in Receivables history runs 13 years deep, the most recent figure standing at -$9.8 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 74.92% year-over-year to -$9.8 million; the TTM figure through Mar 2026 stood at $24.4 million (down 50.73% YoY), while the FY2025 annual figure was -$5.0 million, down 106.24% from the prior year.
- Change in Receivables for Q1 2026 stood at -$9.8 million, down from $33.2 million in the prior quarter.
- The five-year high for Change in Receivables was $62.8 million in Q4 2024, with the low at -$39.2 million in Q1 2025.
- The 5-year median for Change in Receivables is $1.5 million (2022), against an average of $5.7 million.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables surged 5080.0% in 2023, then plunged 366.84% in 2025.
- Harrow's Change in Receivables stood at -$449000.0 in 2022, then jumped by 4121.6% to $18.1 million in 2023, then soared by 247.67% to $62.8 million in 2024, then tumbled by 47.09% to $33.2 million in 2025, then sank by 129.6% to -$9.8 million in 2026.
- Business Quant data shows HROW's Change in Receivables at -$9.8 million in Q1 2026, $33.2 million in Q4 2025, and -$1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | 17.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.20 Mn |
| Jun 30, 2026 | 17.20 Mn |
| Mar 31, 2026 | -9.83 Mn |
| Mar 31, 2026 | -9.83 Mn |
| Dec 31, 2025 | 33.22 Mn |
| Dec 31, 2025 | 33.22 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | -39.20 Mn |
| Mar 31, 2025 | -39.20 Mn |
| Dec 31, 2024 | 62.78 Mn |
| Dec 31, 2024 | 62.78 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 24.03 Mn |
| Jun 30, 2024 | 24.03 Mn |
| Mar 31, 2024 | -8.40 Mn |
| Mar 31, 2024 | -8.40 Mn |